Sponsor Pipeline

Shijiazhuang Yiling Pharmaceutical Co. Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05876832 A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML… Acute Myeloid Leukemia With FLT3/ITD Mutation Not Yet Recruiting
Phase 2/3
NCT06755944 A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Stroke, Ischemic Enrolling by Invitation
Phase 1
NCT07162116 A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy… Acute Myeloid Leukemia With FLT3/ITD Mutation Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Stroke (1)
Get alerts when Shijiazhuang Yiling Pharmaceutical Co. Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free